Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN AUROBINDO PHARMA LUPIN/
AUROBINDO PHARMA
 
P/E (TTM) x -14.5 14.3 - View Chart
P/BV x 2.6 1.4 183.1% View Chart
Dividend Yield % 0.6 1.5 38.6%  

Financials

 LUPIN   AUROBINDO PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-22
AUROBINDO PHARMA
Mar-22
LUPIN/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2681,064 119.2%   
Low Rs679584 116.2%   
Sales per share (Unadj.) Rs361.0400.3 90.2%  
Earnings per share (Unadj.) Rs-33.245.7 -72.7%  
Cash flow per share (Unadj.) Rs3.364.9 5.0%  
Dividends per share (Unadj.) Rs4.009.00 44.4%  
Avg Dividend yield %0.41.1 37.6%  
Book value per share (Unadj.) Rs263.9419.4 62.9%  
Shares outstanding (eoy) m454.48585.94 77.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.72.1 131.0%   
Avg P/E ratio x-29.318.0 -162.5%  
P/CF ratio (eoy) x296.812.7 2,339.2%  
Price / Book Value ratio x3.72.0 187.7%  
Dividend payout %-12.019.7 -61.2%   
Avg Mkt Cap Rs m442,238482,799 91.6%   
No. of employees `000NANA-   
Total wages/salary Rs m29,89334,509 86.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m164,055234,555 69.9%  
Other income Rs m2,1373,226 66.2%   
Total revenues Rs m166,192237,781 69.9%   
Gross profit Rs m2,15242,566 5.1%  
Depreciation Rs m16,58711,265 147.2%   
Interest Rs m1,428486 293.5%   
Profit before tax Rs m-13,72634,040 -40.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,3727,256 18.9%   
Profit after tax Rs m-15,09726,784 -56.4%  
Gross profit margin %1.318.1 7.2%  
Effective tax rate %-10.021.3 -46.9%   
Net profit margin %-9.211.4 -80.6%  
BALANCE SHEET DATA
Current assets Rs m124,577181,227 68.7%   
Current liabilities Rs m82,76481,560 101.5%   
Net working cap to sales %25.542.5 60.0%  
Current ratio x1.52.2 67.7%  
Inventory Days Days3325 132.2%  
Debtors Days Days9562 151.9%  
Net fixed assets Rs m91,938155,104 59.3%   
Share capital Rs m909586 155.1%   
"Free" reserves Rs m119,006245,174 48.5%   
Net worth Rs m119,915245,760 48.8%   
Long term debt Rs m1,4192,492 56.9%   
Total assets Rs m216,515336,331 64.4%  
Interest coverage x-8.671.0 -12.1%   
Debt to equity ratio x00 116.7%  
Sales to assets ratio x0.80.7 108.6%   
Return on assets %-6.38.1 -77.9%  
Return on equity %-12.610.9 -115.5%  
Return on capital %-10.113.9 -72.9%  
Exports to sales %031.1 0.0%   
Imports to sales %011.9 0.0%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs mNA27,965 0.0%   
Fx inflow Rs m53,59477,245 69.4%   
Fx outflow Rs m38,14331,524 121.0%   
Net fx Rs m15,45145,721 33.8%   
CASH FLOW
From Operations Rs m3,67350,165 7.3%  
From Investments Rs m12,922-32,116 -40.2%  
From Financial Activity Rs m-15,723-29,693 53.0%  
Net Cashflow Rs m872-11,674 -7.5%  

Share Holding

Indian Promoters % 46.8 48.8 96.0%  
Foreign collaborators % 0.3 3.1 9.1%  
Indian inst/Mut Fund % 41.5 38.0 109.1%  
FIIs % 14.3 20.7 68.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 52.9 48.2 109.8%  
Shareholders   382,828 359,684 106.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    SANOFI INDIA    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.